Arthritis psoriatica: vizsgálatok itt: Németország

In Németország 20 Also abroad 116

20 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 10.. Ask the study team whether a trial fits you.

4. fázisTaking people
An open-label, multi-center protocol for patients who have completed a previous Novartis sponsored Secukinumab study and are judged by the investigator to benefit from continued Secukinumab treatment
Where
Berlin
People
339 worldwide
Run by
Novartis Pharma AG
See details and how to joinNCT04638647 · EU 2023-504417-67-00
1. fázisTaking people
A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults
Where
Berlin, Hamburg, Ratingen, Wetzlar
Életkor
18 év and over
People
392 worldwide
Run by
UCB Biopharma SRL
See details and how to joinNCT07290036
3. fázisTaking people
A Study of Baricitinib in Participants From 1 Year to Less Than 18 Years Old With Juvenile Idiopathic Arthritis
Where
Berlin, Hamburg, Heidelberg, Sankt Augustin, Tübingen
Életkor
1 év to 18 év
People
190 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT03773965
3. fázisTaking people
A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
Where
Hamburg, Sankt Augustin
Életkor
3 év to 64 év
People
196 worldwide
Run by
Janssen Research & Development, LLC
See details and how to joinNCT06663332 · EU 2023-509560-16-00
No phaseTaking people
PsoBest - The German Psoriasis Registry
Where
Hamburg
Életkor
18 év and over
People
3500
Run by
Universitätsklinikum Hamburg-Eppendorf
See details and how to joinNCT01848028
3. fázisTaking people
An Open-label Study to Evaluate the Pharmacokinetics and Safety of Bimekizumab in Pediatric Study Participants With Active Juvenile Idiopathic Arthritis Subtypes Enthesitis-related Arthritis (Including Juvenile-onset Ankylosing Spondylitis) and Juvenile Psoriatic Arthritis
Where
Berlin, Dresden, Freiburg im Breisgau, Hamburg, Sankt Augustin, Sendenhorst, Tuebingen
Életkor
2 év to 18 év
People
40 worldwide
Run by
UCB Biopharma SRL
See details and how to joinNCT06668181 · EU 2023-508845-41-00
3. fázisTaking people
Apremilast Pediatric Study in Children With Active Juvenile Psoriatic Arthritis
Where
Berlin, Dresden, Hamburg, Sankt Augustin
Életkor
5 év to 17 év
People
60 worldwide
Run by
Amgen
See details and how to joinNCT04804553 · EU 2023-503435-17-00
3. fázisTaking people
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
Where
Bad Bentheim, Bad Doberan, Berlin, Dresden, Hamburg, Leipzig, Munich, Ratingen
Életkor
18 év and over
People
1088 worldwide
Run by
Takeda
See details and how to joinNCT06671483 · EU 2024-513111-27-00
3. fázisTaking people
A Study to Evaluate the Drug Levels, Efficacy, and Safety of Deucravacitinib (BMS-986165) in Pediatric Participants With Juvenile Psoriatic Arthritis
Where
Erlangen, Hamburg
Életkor
5 év to 17 év
People
60 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT06869551 · EU 2024-517262-41-00
3. fázisTaking people
An unblinded clinical Trial with random assignment to Treatment Groups in adult patients with psoriatic arthrits to evaluate how far immunosuppressive medication can be tapered without recurrence of symptoms
Where
Burghausen, Erlangen, Nuremberg
Életkor
18 év and over
People
370 worldwide
Run by
Universitaetsklinikum Erlangen AöR
See details and how to join2023-508251-39-00 · EU 2023-508251-39-00
1. fázisTaking people
A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)
Where
Freiburg im Breisgau, Herne
Életkor
18 év and over
People
20 worldwide
Run by
UCB Biopharma SRL
See details and how to joinNCT06888193 · EU 2024-518689-29-00
3. fázisTaking people
Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis
Where
Bad Bentheim, Bad Doberan, Berlin, Dresden, Hamburg, Herne, Leipzig, Munich, Ratingen
Életkor
18 év and over
People
1182 worldwide
Run by
Takeda
See details and how to joinNCT07286058 · EU 2025-522586-30-00
3. fázisTaking people
A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
Where
Berlin, Hamburg, Sankt Augustin
Életkor
5 év to 17 év
People
40 worldwide
Run by
AbbVie
See details and how to joinNCT06100744 · EU 2023-506026-36-00
4. fázisTaking people
Prospective, multicentre, open-label clinical trial on the effect of GUSelkumab on the resolution of ultrasound-proven ENThEsitis in patients with pSoriatic arthriTis
Where
Berlin, Cologne, Erlangen, Frankfurt Am Main
Életkor
18 év and over
People
78
Run by
Universitaetsklinikum Erlangen AöR
See details and how to join2024-512459-19-00 · EU 2024-512459-19-00
2. fázisTaking people
A Phase 2, open-label, imaging study to explore the effects of sonelokimab in patients with active psoriatic arthritis or axial spondyloarthritis
Where
Erlangen
Életkor
18 év and over
People
30
Run by
MoonLake Immunotherapeutics AG
See details and how to join2024-514504-13-00 · EU 2024-514504-13-00
3. fázisNot yet taking people in Németország
A study to evaluate the long-term safety, tolerability, and efficacy of subcutaneous sonelokimab in participants with psoriatic arthritis (PsA)
Where
Bad Bentheim, Berlin, Erlangen, Frankfurt Am Main, Hamburg, Herne, München, Munich
Életkor
18 év and over
People
948 worldwide
Run by
MoonLake Immunotherapeutics AG
See details and how to join2025-522471-28-00 · EU 2025-522471-28-00
No phaseTaking people
An Ex-US Study to Assess Treatment Persistence With Risankizumab in Adult Participants With Psoriatic Arthritis
Where
Altenburg, Amberg, Berlin, Braunschweig, Frankfurt am Main, Greifswald, Halle, Hanover, Hohen Neuendorf, Kaiserslautern, Kassel, Lübeck, Magdeburg, Planegg, Püttlingen, Ratingen, Rendsburg, Templin, Trier, Wetzlar, Wuppertal
Életkor
18 év to 75 év
People
1200 worldwide
Run by
AbbVie
See details and how to joinNCT06764693
No phaseTaking people
Clinical Assessment for Rheumatologic Disease - Research and Advancement in Safety and Efficacy
Where
Bonn
Életkor
18 év and over
People
120
Run by
University of Bonn
See details and how to joinNCT07150000
No phaseTaking people
AYLo - AutoimmunitY and Loss of y
Where
Bonn
Életkor
50 év and over
People
500
Run by
University of Bonn
See details and how to joinNCT06696027
No phaseTaking people
German Spondyloarthritis Inception Cohort
Where
Berlin
People
1000
Run by
Charite University, Berlin, Germany
See details and how to joinNCT01277419